Innovent Biologics of Suzhou plans to raise $422 million in its Hong Kong IPO at a $2 billion valuation, according to multiple media reports (see story). The company, formed in 2011, struck a major $1 …
( read original story …)
The HongKong News
Innovent Biologics of Suzhou plans to raise $422 million in its Hong Kong IPO at a $2 billion valuation, according to multiple media reports (see story). The company, formed in 2011, struck a major $1 …
( read original story …)